Graves-PCD: protocol for a randomised, dose-finding, adaptive trial of the plasma cell-depleting agent daratumumab in severe Graves' disease.
第一作者:
Faye,Wolstenhulme
第一单位:
Newcastle Clinical Trials Unit, Newcastle University, Newcastle upon Tyne, UK.
作者:
主题词
成年人(Adult);女(雌)性(Female);人类(Humans);男(雄)性(Male);抗体, 单克隆(Antibodies, Monoclonal);剂量效应关系, 药物(Dose-Response Relationship, Drug);格雷夫斯病(Graves Disease);浆细胞(Plasma Cells);随机对照试验(主题)(Randomized Controlled Trials as Topic);单盲法(Single-Blind Method)
DOI
10.1136/bmjopen-2023-079158
PMID
38866568
发布时间
2024-09-09
- 浏览0

BMJ open
e079158页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文